Gilkey Melissa B, Calo William A, Marciniak Macary W, Brewer Noel T
a Department of Population Medicine , Harvard Medical School & Harvard Pilgrim Health Care Institute , Boston , MA , USA.
b Department of Health Policy and Management , University of North Carolina , Chapel Hill , NC , USA.
Hum Vaccin Immunother. 2017 Mar 4;13(3):680-686. doi: 10.1080/21645515.2016.1247134. Epub 2016 Oct 20.
We sought to estimate the national prevalence of HPV vaccine refusal and delay in a nationally-representative sample of parents of adolescents. We also compared parents who refused versus delayed HPV vaccine in terms of their vaccination beliefs and clinical communication preferences.
In 2014 to 2015, we conducted an online survey of 1,484 US parents who reported on an 11- to 17-year-old child in their household. We used weighted multinomial logistic regression to assess correlates of HPV vaccine refusal and delay.
Overall, 28% of parents reported that they had ever "refused or decided not to get" HPV vaccine for their child, and an additional 8% of parents reported that they had "delayed or put off getting" HPV vaccine. Compared to no refusal/delay, refusal was associated with lower confidence in adolescent vaccination (relative risk ratio [RRR] = 0.66, 95% confidence interval [CI], 0.48-0.91), lower perceived HPV vaccine effectiveness (RRR = 0.68, 95% CI, 0.50-0.91), and higher perceived harms (RRR = 3.49, 95% CI, 2.65-4.60). In contrast, delay was associated with needing more information (RRR = 1.76, 95% CI, 1.08-2.85). Most parents rated physicians and information sheets as helpful for making decisions about HPV vaccination, although parents who reported refusal endorsed these resources less often.
Our findings suggest that HPV vaccine refusal is common among parents of adolescents and may have increased relative to previous estimates. Because the vaccination beliefs and communication preferences of parents who refuse appear to differ from those who delay, targeted communication strategies may be needed to effectively address HPV vaccine hesitancy.
我们试图在全国具有代表性的青少年家长样本中,估计HPV疫苗拒绝接种和延迟接种的全国流行率。我们还比较了拒绝接种与延迟接种HPV疫苗的家长在疫苗接种观念和临床沟通偏好方面的差异。
2014年至2015年,我们对1484名美国父母进行了一项在线调查,这些父母报告了家中一名11至17岁的孩子。我们使用加权多项逻辑回归来评估HPV疫苗拒绝接种和延迟接种的相关因素。
总体而言,28%的父母报告称他们曾“拒绝或决定不给”孩子接种HPV疫苗,另有8%的父母报告称他们“延迟或推迟了”HPV疫苗接种。与未拒绝/延迟接种相比,拒绝接种与对青少年接种疫苗的信心较低(相对风险比[RRR]=0.66,95%置信区间[CI],0.48-0.91)、对HPV疫苗有效性的认知较低(RRR=0.68,95%CI,0.50-0.91)以及对危害的认知较高(RRR=3.49,95%CI,2.65-4.60)相关。相比之下,延迟接种与需要更多信息相关(RRR=1.76,95%CI,1.08-2.85)。大多数父母认为医生和信息表对做出HPV疫苗接种决策有帮助,尽管报告拒绝接种的父母对这些资源的认可较少。
我们的研究结果表明,HPV疫苗拒绝接种在青少年家长中很常见,且可能比之前的估计有所增加。由于拒绝接种的父母的疫苗接种观念和沟通偏好似乎与延迟接种的父母不同,可能需要有针对性的沟通策略来有效解决HPV疫苗犹豫问题。